Pharma & Healthcare
Global Andrographolide Tablets Market Research Report 2026
- Feb 03, 26
- ID: 698107
- Pages: 112
- Figures: 116
- Views: 3
This report delivers a comprehensive overview of the global Andrographolide Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Andrographolide Tablets. The Andrographolide Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Andrographolide Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Andrographolide Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
Henan Furentang Pharmaceutical Co., Ltd.
Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Co., Ltd.
Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
Guangdong Wannianqing Pharmaceutical Co., Ltd.
Sinopharm Group Yibin Pharmaceutical Co., Ltd.
Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
Hubei Keyi Pharmaceutical Co., Ltd.
Segment by Type
Dispersible Tablets
Conventional Tablets
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Andrographolide Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Andrographolide Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Andrographolide Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Andrographolide Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
Henan Furentang Pharmaceutical Co., Ltd.
Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Co., Ltd.
Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
Guangdong Wannianqing Pharmaceutical Co., Ltd.
Sinopharm Group Yibin Pharmaceutical Co., Ltd.
Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
Hubei Keyi Pharmaceutical Co., Ltd.
Segment by Type
Dispersible Tablets
Conventional Tablets
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Andrographolide Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Andrographolide Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Andrographolide Tablets Market Overview
1.1 Product Definition
1.2 Andrographolide Tablets by Type
1.2.1 Global Andrographolide Tablets Market Value by Type: 2025 vs 2032
1.2.2 Dispersible Tablets
1.2.3 Conventional Tablets
1.3 Andrographolide Tablets by Application
1.3.1 Global Andrographolide Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Andrographolide Tablets Market Size Estimates and Forecasts
1.4.1 Global Andrographolide Tablets Revenue 2021–2032
1.4.2 Global Andrographolide Tablets Sales 2021–2032
1.4.3 Global Andrographolide Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Andrographolide Tablets Market Competition by Manufacturers
2.1 Global Andrographolide Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Andrographolide Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Andrographolide Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Andrographolide Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Andrographolide Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Andrographolide Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Andrographolide Tablets, Date of Entry into the Industry
2.8 Global Andrographolide Tablets Market Competitive Situation and Trends
2.8.1 Global Andrographolide Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Andrographolide Tablets Players Market Share by Revenue
2.8.3 Global Andrographolide Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Andrographolide Tablets Market Scenario by Region
3.1 Global Andrographolide Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Andrographolide Tablets Sales by Region: 2021–2032
3.2.1 Global Andrographolide Tablets Sales by Region: 2021–2026
3.2.2 Global Andrographolide Tablets Sales by Region: 2027–2032
3.3 Global Andrographolide Tablets Revenue by Region: 2021–2032
3.3.1 Global Andrographolide Tablets Revenue by Region: 2021–2026
3.3.2 Global Andrographolide Tablets Revenue by Region: 2027–2032
3.4 North America Andrographolide Tablets Market Facts & Figures by Country
3.4.1 North America Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Andrographolide Tablets Sales by Country (2021–2032)
3.4.3 North America Andrographolide Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographolide Tablets Market Facts & Figures by Country
3.5.1 Europe Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Andrographolide Tablets Sales by Country (2021–2032)
3.5.3 Europe Andrographolide Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographolide Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Andrographolide Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Andrographolide Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Andrographolide Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Andrographolide Tablets Market Facts & Figures by Country
3.7.1 Latin America Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Andrographolide Tablets Sales by Country (2021–2032)
3.7.3 Latin America Andrographolide Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Andrographolide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Andrographolide Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Andrographolide Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographolide Tablets Sales by Type (2021–2032)
4.1.1 Global Andrographolide Tablets Sales by Type (2021–2026)
4.1.2 Global Andrographolide Tablets Sales by Type (2027–2032)
4.1.3 Global Andrographolide Tablets Sales Market Share by Type (2021–2032)
4.2 Global Andrographolide Tablets Revenue by Type (2021–2032)
4.2.1 Global Andrographolide Tablets Revenue by Type (2021–2026)
4.2.2 Global Andrographolide Tablets Revenue by Type (2027–2032)
4.2.3 Global Andrographolide Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Andrographolide Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Andrographolide Tablets Sales by Application (2021–2032)
5.1.1 Global Andrographolide Tablets Sales by Application (2021–2026)
5.1.2 Global Andrographolide Tablets Sales by Application (2027–2032)
5.1.3 Global Andrographolide Tablets Sales Market Share by Application (2021–2032)
5.2 Global Andrographolide Tablets Revenue by Application (2021–2032)
5.2.1 Global Andrographolide Tablets Revenue by Application (2021–2026)
5.2.2 Global Andrographolide Tablets Revenue by Application (2027–2032)
5.2.3 Global Andrographolide Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Andrographolide Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
6.1.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
6.1.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.1.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
6.1.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.2 Henan Furentang Pharmaceutical Co., Ltd.
6.2.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
6.2.2 Henan Furentang Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.2.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
6.3.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
6.3.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.3.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
6.4.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
6.4.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.4.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
6.5.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
6.5.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Description and Business Overview
6.5.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
6.5.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
6.6 Guangdong Wannianqing Pharmaceutical Co., Ltd.
6.6.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
6.6.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.6.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
6.7.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
6.7.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.7.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
6.8.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
6.8.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.8.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Hubei Keyi Pharmaceutical Co., Ltd.
6.9.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
6.9.2 Hubei Keyi Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.9.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographolide Tablets Industry Chain Analysis
7.2 Andrographolide Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographolide Tablets Production Mode & Process Analysis
7.4 Andrographolide Tablets Sales and Marketing
7.4.1 Andrographolide Tablets Sales Channels
7.4.2 Andrographolide Tablets Distributors
7.5 Andrographolide Tablets Customer Analysis
8 Andrographolide Tablets Market Dynamics
8.1 Andrographolide Tablets Industry Trends
8.2 Andrographolide Tablets Market Drivers
8.3 Andrographolide Tablets Market Challenges
8.4 Andrographolide Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Andrographolide Tablets by Type
1.2.1 Global Andrographolide Tablets Market Value by Type: 2025 vs 2032
1.2.2 Dispersible Tablets
1.2.3 Conventional Tablets
1.3 Andrographolide Tablets by Application
1.3.1 Global Andrographolide Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Andrographolide Tablets Market Size Estimates and Forecasts
1.4.1 Global Andrographolide Tablets Revenue 2021–2032
1.4.2 Global Andrographolide Tablets Sales 2021–2032
1.4.3 Global Andrographolide Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Andrographolide Tablets Market Competition by Manufacturers
2.1 Global Andrographolide Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Andrographolide Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Andrographolide Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Andrographolide Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Andrographolide Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Andrographolide Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Andrographolide Tablets, Date of Entry into the Industry
2.8 Global Andrographolide Tablets Market Competitive Situation and Trends
2.8.1 Global Andrographolide Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Andrographolide Tablets Players Market Share by Revenue
2.8.3 Global Andrographolide Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Andrographolide Tablets Market Scenario by Region
3.1 Global Andrographolide Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Andrographolide Tablets Sales by Region: 2021–2032
3.2.1 Global Andrographolide Tablets Sales by Region: 2021–2026
3.2.2 Global Andrographolide Tablets Sales by Region: 2027–2032
3.3 Global Andrographolide Tablets Revenue by Region: 2021–2032
3.3.1 Global Andrographolide Tablets Revenue by Region: 2021–2026
3.3.2 Global Andrographolide Tablets Revenue by Region: 2027–2032
3.4 North America Andrographolide Tablets Market Facts & Figures by Country
3.4.1 North America Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Andrographolide Tablets Sales by Country (2021–2032)
3.4.3 North America Andrographolide Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographolide Tablets Market Facts & Figures by Country
3.5.1 Europe Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Andrographolide Tablets Sales by Country (2021–2032)
3.5.3 Europe Andrographolide Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographolide Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Andrographolide Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Andrographolide Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Andrographolide Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Andrographolide Tablets Market Facts & Figures by Country
3.7.1 Latin America Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Andrographolide Tablets Sales by Country (2021–2032)
3.7.3 Latin America Andrographolide Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Andrographolide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographolide Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Andrographolide Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Andrographolide Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographolide Tablets Sales by Type (2021–2032)
4.1.1 Global Andrographolide Tablets Sales by Type (2021–2026)
4.1.2 Global Andrographolide Tablets Sales by Type (2027–2032)
4.1.3 Global Andrographolide Tablets Sales Market Share by Type (2021–2032)
4.2 Global Andrographolide Tablets Revenue by Type (2021–2032)
4.2.1 Global Andrographolide Tablets Revenue by Type (2021–2026)
4.2.2 Global Andrographolide Tablets Revenue by Type (2027–2032)
4.2.3 Global Andrographolide Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Andrographolide Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Andrographolide Tablets Sales by Application (2021–2032)
5.1.1 Global Andrographolide Tablets Sales by Application (2021–2026)
5.1.2 Global Andrographolide Tablets Sales by Application (2027–2032)
5.1.3 Global Andrographolide Tablets Sales Market Share by Application (2021–2032)
5.2 Global Andrographolide Tablets Revenue by Application (2021–2032)
5.2.1 Global Andrographolide Tablets Revenue by Application (2021–2026)
5.2.2 Global Andrographolide Tablets Revenue by Application (2027–2032)
5.2.3 Global Andrographolide Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Andrographolide Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
6.1.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
6.1.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.1.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
6.1.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.2 Henan Furentang Pharmaceutical Co., Ltd.
6.2.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
6.2.2 Henan Furentang Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.2.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
6.3.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
6.3.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.3.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
6.4.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
6.4.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.4.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
6.5.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
6.5.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Description and Business Overview
6.5.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
6.5.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
6.6 Guangdong Wannianqing Pharmaceutical Co., Ltd.
6.6.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
6.6.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.6.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
6.7.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
6.7.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.7.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
6.8.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
6.8.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.8.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Hubei Keyi Pharmaceutical Co., Ltd.
6.9.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
6.9.2 Hubei Keyi Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
6.9.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographolide Tablets Industry Chain Analysis
7.2 Andrographolide Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographolide Tablets Production Mode & Process Analysis
7.4 Andrographolide Tablets Sales and Marketing
7.4.1 Andrographolide Tablets Sales Channels
7.4.2 Andrographolide Tablets Distributors
7.5 Andrographolide Tablets Customer Analysis
8 Andrographolide Tablets Market Dynamics
8.1 Andrographolide Tablets Industry Trends
8.2 Andrographolide Tablets Market Drivers
8.3 Andrographolide Tablets Market Challenges
8.4 Andrographolide Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Andrographolide Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Andrographolide Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Andrographolide Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Andrographolide Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Andrographolide Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Andrographolide Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Andrographolide Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Andrographolide Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Andrographolide Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Andrographolide Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Andrographolide Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Andrographolide Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Andrographolide Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Andrographolide Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Andrographolide Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Andrographolide Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Andrographolide Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Andrographolide Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Andrographolide Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Andrographolide Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Andrographolide Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Andrographolide Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Andrographolide Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Andrographolide Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Andrographolide Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Andrographolide Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Andrographolide Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Andrographolide Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Andrographolide Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Andrographolide Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Andrographolide Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Andrographolide Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Andrographolide Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Andrographolide Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Andrographolide Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Andrographolide Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Andrographolide Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Andrographolide Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Andrographolide Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Andrographolide Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Andrographolide Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Andrographolide Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Andrographolide Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Andrographolide Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Andrographolide Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Andrographolide Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Andrographolide Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Andrographolide Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
Table 71. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 72. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product
Table 74. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 75. Henan Furentang Pharmaceutical Co., Ltd. Company Information
Table 76. Henan Furentang Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 79. Henan Furentang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
Table 81. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 84. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
Table 86. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 89. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
Table 91. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Description and Business Overview
Table 92. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product
Table 94. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
Table 95. Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
Table 96. Guangdong Wannianqing Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 99. Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
Table 101. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 104. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
Table 106. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 109. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Hubei Keyi Pharmaceutical Co., Ltd. Company Information
Table 111. Hubei Keyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 114. Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Andrographolide Tablets Distributors List
Table 118. Andrographolide Tablets Customers List
Table 119. Andrographolide Tablets Market Trends
Table 120. Andrographolide Tablets Market Drivers
Table 121. Andrographolide Tablets Market Challenges
Table 122. Andrographolide Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Andrographolide Tablets
Figure 2. Global Andrographolide Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Andrographolide Tablets Market Share by Type: 2025 & 2032
Figure 4. Dispersible Tablets Product Picture
Figure 5. Conventional Tablets Product Picture
Figure 6. Global Andrographolide Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Andrographolide Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Andrographolide Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Andrographolide Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Andrographolide Tablets Sales (K Units), 2021–2032
Figure 14. Global Andrographolide Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Andrographolide Tablets Report Years Considered
Figure 16. Andrographolide Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Andrographolide Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Andrographolide Tablets Players: Market Share by Revenue in Andrographolide Tablets in 2025
Figure 19. Andrographolide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Andrographolide Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Andrographolide Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Andrographolide Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Andrographolide Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Andrographolide Tablets by Type (2021–2032)
Figure 54. Global Andrographolide Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Andrographolide Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Andrographolide Tablets by Application (2021–2032)
Figure 57. Global Andrographolide Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Andrographolide Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Andrographolide Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Andrographolide Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Andrographolide Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Andrographolide Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Andrographolide Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Andrographolide Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Andrographolide Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Andrographolide Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Andrographolide Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Andrographolide Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Andrographolide Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Andrographolide Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Andrographolide Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Andrographolide Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Andrographolide Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Andrographolide Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Andrographolide Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Andrographolide Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Andrographolide Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Andrographolide Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Andrographolide Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Andrographolide Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Andrographolide Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Andrographolide Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Andrographolide Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Andrographolide Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Andrographolide Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Andrographolide Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Andrographolide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Andrographolide Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Andrographolide Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Andrographolide Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Andrographolide Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Andrographolide Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Andrographolide Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Andrographolide Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Andrographolide Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Andrographolide Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Andrographolide Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Andrographolide Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Andrographolide Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Andrographolide Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Andrographolide Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Andrographolide Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Andrographolide Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Andrographolide Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Andrographolide Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Andrographolide Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Andrographolide Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Andrographolide Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Andrographolide Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Andrographolide Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Andrographolide Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
Table 71. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 72. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product
Table 74. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 75. Henan Furentang Pharmaceutical Co., Ltd. Company Information
Table 76. Henan Furentang Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 79. Henan Furentang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
Table 81. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 84. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
Table 86. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 89. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
Table 91. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Description and Business Overview
Table 92. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product
Table 94. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
Table 95. Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
Table 96. Guangdong Wannianqing Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 99. Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
Table 101. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 104. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
Table 106. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 109. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Hubei Keyi Pharmaceutical Co., Ltd. Company Information
Table 111. Hubei Keyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product
Table 114. Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Andrographolide Tablets Distributors List
Table 118. Andrographolide Tablets Customers List
Table 119. Andrographolide Tablets Market Trends
Table 120. Andrographolide Tablets Market Drivers
Table 121. Andrographolide Tablets Market Challenges
Table 122. Andrographolide Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Andrographolide Tablets
Figure 2. Global Andrographolide Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Andrographolide Tablets Market Share by Type: 2025 & 2032
Figure 4. Dispersible Tablets Product Picture
Figure 5. Conventional Tablets Product Picture
Figure 6. Global Andrographolide Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Andrographolide Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Andrographolide Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Andrographolide Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Andrographolide Tablets Sales (K Units), 2021–2032
Figure 14. Global Andrographolide Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Andrographolide Tablets Report Years Considered
Figure 16. Andrographolide Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Andrographolide Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Andrographolide Tablets Players: Market Share by Revenue in Andrographolide Tablets in 2025
Figure 19. Andrographolide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Andrographolide Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Andrographolide Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Andrographolide Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Andrographolide Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Andrographolide Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Andrographolide Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Andrographolide Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Andrographolide Tablets by Type (2021–2032)
Figure 54. Global Andrographolide Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Andrographolide Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Andrographolide Tablets by Application (2021–2032)
Figure 57. Global Andrographolide Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Andrographolide Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232